Theralase Net Income Applicable To Common Shares from 2010 to 2025
| TLT Stock | CAD 0.27 0.01 3.57% |
Net Loss | First Reported 2016-12-31 | Previous Quarter -1.2 M | Current Value -1.2 M | Quarterly Volatility 466 K |
Check Theralase Technologies financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Theralase Technologies' main balance sheet or income statement drivers, such as Depreciation And Amortization of 345.5 K, Interest Expense of 36.7 K or Other Operating Expenses of 4.2 M, as well as many indicators such as Price To Sales Ratio of 40.42, Dividend Yield of 0.0 or PTB Ratio of 13.26. Theralase financial statements analysis is a perfect complement when working with Theralase Technologies Valuation or Volatility modules.
Theralase | Net Income Applicable To Common Shares |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Theralase Stock Analysis
When running Theralase Technologies' price analysis, check to measure Theralase Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Theralase Technologies is operating at the current time. Most of Theralase Technologies' value examination focuses on studying past and present price action to predict the probability of Theralase Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Theralase Technologies' price. Additionally, you may evaluate how the addition of Theralase Technologies to your portfolios can decrease your overall portfolio volatility.